{
    "symbol": "PAHC",
    "quarter": 3,
    "year": 2022,
    "date": "2022-05-08 07:44:03",
    "content": " Consolidated net sales for the quarter ended March 31, 2022, were $239.6 million, reflecting a $27.9 million or 13% increase over the same quarter one year ago. The Animal Health segment posted $148.6 million of net sales for the quarter, which represents an increase of $14.2 million or 11% versus the same quarter of prior year. Within the Animal Health segment, we reported a $5.8 million or 7% increase in MFAs and other versus the same quarter of prior year, driven by increased sales of processing aids used to improve production efficiency in the ethanol fermentation industry. In terms of profitability for the segment, Animal Health adjusted EBITDA was $29.2 million, a 6% decline from the same quarter prior year in dollar terms and a 330 basis point decline in adjusted EBITDA margin due to the challenges Jack highlighted in his opening remarks and an increase in SG&A expenses. Starting with Mineral Nutrition, net sales for the third quarter were $69 million, an increase of $10.9 million or 19% versus the same quarter prior year, driven by higher average selling prices of trace minerals, correlated with the movement of the underlying raw material costs. Mineral Nutrition adjusted EBITDA was $7.3 million, reflecting year-on-year growth of $2.1 million or 40% and reflects an improvement in adjusted EBITDA margin of 160 basis points, driven by increased gross profit derived from the higher average selling prices. Net sales of $22 million for the three months ended March 31, 2022, reflects a $2.8 million or 15% improvement over the same quarter prior year as a result of higher volumes of ingredients for personal care products and higher volumes and average selling prices of copper-based products."
}